RSH 7.41% 2.9¢ respiri limited

Ann: New GBP2m NIHR-Funded UK Paediatric Asthma Clinical Trial, page-26

  1. 265 Posts.
    lightbulb Created with Sketch. 40
    Agree, THE key mesure for a sustainable business is active paying subscribers. The current situation I would see that as supporting a view that DTC in this space is very challanging, asthma is a complex multifactorial disease, patients have complex motivations as to why they do / don't adhere or use technologies. Hence the impotance for successful US commercialsation for adoption to be physician led / sponsored and financially positive for the US physician.
 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
2.9¢
Change
0.002(7.41%)
Mkt cap ! $33.24M
Open High Low Value Volume
2.9¢ 2.9¢ 2.9¢ $17.72K 611.3K

Buyers (Bids)

No. Vol. Price($)
1 152245 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 190928 1
View Market Depth
Last trade - 15.39pm 12/07/2024 (20 minute delay) ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.